Progress in immunoconjugate cancer therapeutics

This publication has 22 references indexed in Scilit:

• Radioimmunotherapy of non-Hodgkin lymphomas
  Blood, 2003
• Toxin-Labeled Monoclonal Antibodies
  Current Pharmaceutical Biotechnology, 2001
• Tumor Therapy with Targeted Atomic Nanogenerators
  Science, 2001
• High-throughput generation and engineering of recombinant human antibodies
  Journal of Immunological Methods, 2001
• Efficacy of the Anti-CD22 Recombinant Immunotoxin BL22 in Chemotherapy-Resistant Hairy-Cell Leukemia
  New England Journal of Medicine, 2001
• Phase I Trial of Recombinant Immunotoxin Anti-Tac(Fv)-PE38 (LMB-2) in Patients With Hematologic Malignancies
  Journal of Clinical Oncology, 2000
• Synthesis and Biological Evaluation of 2-Acyl Analogues of Paclitaxel (Taxol)
  Journal of Medicinal Chemistry, 1998
• Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy
  Advanced Drug Delivery Reviews, 1998
• The Cytotoxicity and Microdosimetry of Astatine-211-Labeled Chimeric Monoclonal Antibodies in Human Glioma and Melanoma Cells In Vitro
  Radiation Research, 1998
• Eradication of large colon tumor xenografts by targeted delivery of maytansinoids.
  Proceedings of the National Academy of Sciences, 1996